357 related articles for article (PubMed ID: 30910864)
21. An overview of precision oncology basket and umbrella trials for clinicians.
Park JJH; Hsu G; Siden EG; Thorlund K; Mills EJ
CA Cancer J Clin; 2020 Mar; 70(2):125-137. PubMed ID: 32031692
[TBL] [Abstract][Full Text] [Related]
22. Future Approaches to Precision Oncology-Based Clinical Trials.
Mittra A; Moscow JA
Cancer J; 2019; 25(4):300-304. PubMed ID: 31335395
[TBL] [Abstract][Full Text] [Related]
23. Ushering in the next generation of precision trials for pediatric cancer.
DuBois SG; Corson LB; Stegmaier K; Janeway KA
Science; 2019 Mar; 363(6432):1175-1181. PubMed ID: 30872517
[TBL] [Abstract][Full Text] [Related]
24. Precision oncology in Latin America: current situation, challenges and perspectives.
Calderón-Aparicio A; Orue A
Ecancermedicalscience; 2019; 13():920. PubMed ID: 31281417
[TBL] [Abstract][Full Text] [Related]
25. Making Molecular Imaging a Clinical Tool for Precision Oncology: A Review.
Mankoff DA; Farwell MD; Clark AS; Pryma DA
JAMA Oncol; 2017 May; 3(5):695-701. PubMed ID: 28033451
[TBL] [Abstract][Full Text] [Related]
26. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.
Higashida RT; Furlan AJ; Roberts H; Tomsick T; Connors B; Barr J; Dillon W; Warach S; Broderick J; Tilley B; Sacks D; ;
Stroke; 2003 Aug; 34(8):e109-37. PubMed ID: 12869717
[TBL] [Abstract][Full Text] [Related]
27. Evidence-Based Precision Oncology with the Cancer Targetome.
Blucher AS; Choonoo G; Kulesz-Martin M; Wu G; McWeeney SK
Trends Pharmacol Sci; 2017 Dec; 38(12):1085-1099. PubMed ID: 28964549
[TBL] [Abstract][Full Text] [Related]
28. Definitions and statistical properties of master protocols for personalized medicine in oncology.
Renfro LA; Mandrekar SJ
J Biopharm Stat; 2018; 28(2):217-228. PubMed ID: 28877008
[TBL] [Abstract][Full Text] [Related]
29. Personalized Medicine: Genomics Trials in Oncology.
Hayes DF; Schott AF
Trans Am Clin Climatol Assoc; 2015; 126():133-43. PubMed ID: 26330667
[TBL] [Abstract][Full Text] [Related]
30. Precision Oncology for Cancer Immunotherapies in Early-Phase Clinical Trials.
Paliard X; Rixe O
Target Oncol; 2019 Dec; 14(6):631-637. PubMed ID: 31595386
[TBL] [Abstract][Full Text] [Related]
31. Current globalization of drug interventional clinical trials: characteristics and associated factors, 2011-2013.
Jeong S; Sohn M; Kim JH; Ko M; Seo HW; Song YK; Choi B; Han N; Na HS; Lee JG; Kim IW; Oh JM; Lee E
Trials; 2017 Jun; 18(1):288. PubMed ID: 28637515
[TBL] [Abstract][Full Text] [Related]
32. Precision oncology: the intention-to-treat analysis fallacy.
Sicklick JK; Kato S; Okamura R; Kurzrock R
Eur J Cancer; 2020 Jul; 133():25-28. PubMed ID: 32422506
[TBL] [Abstract][Full Text] [Related]
33. A clinical pharmacy pilot within a Precision Medicine Program for cancer patients and review of related pharmacist clinical practice.
Arnall JR; Petro R; Patel JN; Kennedy L
J Oncol Pharm Pract; 2019 Jan; 25(1):179-186. PubMed ID: 29078708
[TBL] [Abstract][Full Text] [Related]
34. Precision medicine clinical trials: defining new treatment strategies.
Heckman-Stoddard BM; Smith JJ
Semin Oncol Nurs; 2014 May; 30(2):109-16. PubMed ID: 24794084
[TBL] [Abstract][Full Text] [Related]
35. Personalised and Precision Medicine in Cancer Clinical Trials: Panacea for Progress or Pandora's Box?
Lawler M; Sullivan R
Public Health Genomics; 2015; 18(6):329-37. PubMed ID: 26555236
[TBL] [Abstract][Full Text] [Related]
36. Some Lingering Concerns about the Precision Medicine Initiative: Currents in Contemporary Bioethics.
Rothstein MA
J Law Med Ethics; 2016 Sep; 44(3):520-5. PubMed ID: 27587456
[No Abstract] [Full Text] [Related]
37. The clinical trial landscape in oncology and connectivity of somatic mutational profiles to targeted therapies.
Patterson SE; Liu R; Statz CM; Durkin D; Lakshminarayana A; Mockus SM
Hum Genomics; 2016 Jan; 10():4. PubMed ID: 26772741
[TBL] [Abstract][Full Text] [Related]
38. Complexity of Delivering Precision Medicine: Opportunities and Challenges.
Davis AA; McKee AE; Kibbe WA; Villaflor VM
Am Soc Clin Oncol Educ Book; 2018 May; 38():998-1007. PubMed ID: 30231318
[TBL] [Abstract][Full Text] [Related]
39. The FDA Oncology Center of Excellence and precision medicine.
Goldberg KB; Blumenthal GM; McKee AE; Pazdur R
Exp Biol Med (Maywood); 2018 Feb; 243(3):308-312. PubMed ID: 29105511
[TBL] [Abstract][Full Text] [Related]
40. Implementing precision oncology in Latin America to improve patient outcomes: the status quo and a call to action for key stakeholders and decision-makers.
de Castilla EMR; Mayrides M; González H; Vidangossy F; Corbeaux T; Ortiz N; Amaya C; Nuñez A; Jimbo DFJ; Ayensa A; Galindo M; Ruiz K; Pérez JM
Ecancermedicalscience; 2024; 18():1653. PubMed ID: 38425763
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
